Literature DB >> 23916504

Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.

Kristian Gaarn du Jardin1, Jesper Bornø Jensen2, Connie Sanchez2, Alan L Pehrson2.   

Abstract

We previously reported that the investigational multimodal antidepressant, vortioxetine, reversed 5-HT depletion-induced memory deficits while escitalopram and duloxetine did not. The present report studied the effects of vortioxetine and the potential impact of its 5-HT1A receptor agonist and 5-HT3 receptor antagonist properties on 5-HT depletion-induced memory deficits. Recognition and spatial working memory were assessed in the object recognition (OR) and Y-maze spontaneous alternation (SA) tests, respectively. 5-HT depletion was induced in female Long-Evans rats using 4-cholro-DL-phenylalanine methyl ester HCl (PCPA) and receptor occupancies were determined by ex vivo autoradiography. Rats were acutely dosed with vortioxetine, ondansetron (5-HT3 receptor antagonist) or flesinoxan (5-HT1A receptor agonist). The effects of chronic vortioxetine administration on 5-HT depletion-induced memory deficits were also assessed. 5-HT depletion reliably impaired memory performance in both the tests. Vortioxetine reversed PCPA-induced memory deficits dose-dependently with a minimal effective dose (MED) ≤0.1mg/kg (∼80% 5-HT3 receptor occupancy; OR) and ≤3.0mg/kg (5-HT1A, 5-HT1B, 5-HT3 receptor occupancy: ∼15%, 60%, 95%) in SA. Ondansetron exhibited a MED ≤3.0μg/kg (∼25% 5-HT3 receptor occupancy; OR), but was inactive in the SA test. Flesinoxan had a MED ≤1.0mg/kg (∼25% 5-HT1A receptor occupancy; SA); only 1.0mg/kg ameliorated deficits in the NOR. Chronic p.o. vortioxetine administration significantly improved memory performance in OR and occupied 95%, 66%, and 9.5% of 5-HT3, 5-HT1B, and 5-HT1A receptors, respectively. Vortioxetine's effects on SA performance may involve 5-HT1A receptor agonism, but not 5-HT3 receptor antagonism, whereas the effects on OR performance may involve 5-HT3 receptor antagonism and 5-HT1A receptor agonism.
Copyright © 2013 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  5-HT depletion; 5-HT(1A) receptor; 5-HT(3) receptor; Cognitive dysfunction; Major depressive disorder; Vortioxetine

Mesh:

Substances:

Year:  2013        PMID: 23916504     DOI: 10.1016/j.euroneuro.2013.07.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  37 in total

Review 1.  A brief history of the development of antidepressant drugs: from monoamines to glutamate.

Authors:  Todd M Hillhouse; Joseph H Porter
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

Review 2.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

Review 3.  Vortioxetine: a review of its use in major depressive disorder.

Authors:  Karly P Garnock-Jones
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

4.  Constitutive and Acquired Serotonin Deficiency Alters Memory and Hippocampal Synaptic Plasticity.

Authors:  Sebastian P Fernandez; Aude Muzerelle; Sophie Scotto-Lomassese; Jacques Barik; Agnès Gruart; José M Delgado-García; Patricia Gaspar
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

5.  Pharmacological Management of Anxiety Disorders in the Elderly.

Authors:  Elizabeth A Crocco; Sindy Jaramillo; Caroline Cruz-Ortiz; Katherine Camfield
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-10

6.  Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.

Authors:  Kristian Gaarn du Jardin; Nico Liebenberg; Heidi Kaastrup Müller; Betina Elfving; Connie Sanchez; Gregers Wegener
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

7.  Vortioxetine: first global approval.

Authors:  Andrew Gibb; Emma D Deeks
Journal:  Drugs       Date:  2014-01       Impact factor: 9.546

8.  Effect of ramosetron, a 5-HT3 receptor antagonist on the severity of seizures and memory impairment in electrical amygdala kindled rats.

Authors:  Zeynab Sayahi; Alireza Komaki; Masoud Saidi Jam; Seyed Asaad Karimi; Safoura Raoufi; Parastoo Mardani; Marzieh Naderishahab; Abdolrahman Sarihi; Javad Mirnajafi-Zadeh
Journal:  J Physiol Sci       Date:  2022-01-16       Impact factor: 2.781

9.  Anabolic-androgenic steroids and cognitive effort discounting in male rats.

Authors:  Lisa B Dokovna; Grace Li; Ruth I Wood
Journal:  Horm Behav       Date:  2019-05-08       Impact factor: 3.587

10.  Crystal structures of vortioxetine and its methanol monosolvate.

Authors:  Xin-Bo Zhou; Jian-Ming Gu; Meng-Ying Sun; Xiu-Rong Hu; Su-Xiang Wu
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.